Effects of lipopolysaccharide on low- and high-density cultured rabbit vascular smooth muscle cells: Differential modulation of nitric oxide release, ERK1/ERK2 MAP kinase activity, protein tyrosine phosphatase activity, and DNA synthesis

Brazilian Journal of Medical and Biological Research

Volumn 35, Issue 2, 2002, Pages 181-190

  De Barbosa Oliveira, L C ^a   Rocha Oliveira, C J ^a,b   Fries, D M ^a   Stern, A ^c   Monteiro, H P ^a  

^a FUNDAÇÃO PRÓ SANGUE HEMOCENTRO DE SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cell density; DNA synthesis; Lipopolysaccharide; Mitogen activated protein kinases; Nitric oxide; Protein tyrosine phosphatases

Indexed keywords

AMINOGUANIDINE; BACTERIUM LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; OXYHEMOGLOBIN; PROTEIN TYROSINE PHOSPHATASE; SCAVENGER;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CULTURE; CELL DENSITY; CELL PROLIFERATION; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEPHOSPHORYLATION; DNA SYNTHESIS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ESCHERICHIA COLI; INCUBATION TIME; MITOGENICITY; NONHUMAN; PHOSPHORYLATION; RABBIT; SIGNAL TRANSDUCTION; STATISTICAL ANALYSIS; TRANSCRIPTION INITIATION; VASCULAR SMOOTH MUSCLE;

ANIMALIA; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; ORYCTOLAGUS CUNICULUS;

EID: 0036118617     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/s0100-879x2002000200006     Document Type: Article

References (40)

1. Regulation of differentiated properties and proliferation of aortic smooth muscle cells
2. The pathogenesis of atherosclerosis: A perspective for the 1990's
3. The restenosis paradigm revisited: An alternative proposal for mechanisms
4. NO-generating vasodilators and 8-bromo cGMP inhibit mitogenesis and proliferation of cultured vascular smooth muscle cells
5. NO donor molecules: Effect of NO release rate on vascular smooth muscle cell proliferation in vitro
6. NO mediated cytotoxicity and bFGF release in cultured smooth muscle cells
7. The smooth muscle cells in culture
8. Arterial smooth muscle cells express PDGFa mRNA, secrete a PDGF-like mitogen and bind exogenous PDGF in a phenotype- and growth state-dependent manner
9. Nitric oxide synthases in mammals
10. Quantitative and kinetic characterization of nitric oxide and EDRF released from cultured endothelial cells
11. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein
12. Activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside and nitrosoguanidine - Inhibition by calcium, lanthanum, and other cations, enhancement by thiols
13. Nitric oxide-stimulated guanine nucleotide exchange on p21Ras
14. Nitric oxide stimulates tyrosine phosphorylation in murine fibroblasts in the presence and absence of epidermal growth factor
15. Nitric oxide and superoxide inhibit platelet-derived growth factor receptor phosphotyrosine phosphatases
16. Nitric oxide stimulates tyrosine phosphorylation of focal adhesion kinase, Src kinase, and mitogen activated protein kinases in murine fibroblasts
17. Growth factor signaling by receptor tyrosine kinases
18. NO mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by SP
19. Middle T-antigen-transformed endothelial cells exhibit an increased activity of NO synthase
20. Importance of tyrosine phosphatases in the effects of cell-cell contact and microenvironments on EGF-stimulated tyrosine phosphorylation
21. Activation of the mitogen-activated protein kinase signaling pathway in neutrophils
22. Tyrosine phosphorylation of a mitogen-activated protein kinase-like protein occurs at a late step in exocytosis
23. Organization and regulation of mitogen-activated protein kinase signaling pathways
24. Preparation of blood hemoglobins of vertebrates
25. Hormone and surface receptors in vascular endothelium
26. Point mutation at the ATP binding site of EGF receptor abolishes proteintyrosine kinase activity and alters cellular routing
27. Inhibition of protein tyrosine phosphatase activity by diamide is reversed by epidermal growth factor in fibroblasts
28. Kinetic modeling of the nitric oxide gradient generated in vitro by adherent cells expressing inducible nitric oxide synthase
29. Selective inhibition of the inducible nitric oxide synthase by aminoguanidine
30. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide
31. NO mediates suppression of T cell responses in murine T. brucei infection
32. NO suppression of human hematopoiesis in vitro
33. Is NO an endogenous antiatherogenic molecule?
34. Roles of NO in tumor growth
35. Regulation of endothelial NO synthase mRNA, protein, and activity during cell growth
36. Negative growth control by a novel low M(r) phosphotyrosine protein phosphatase in normal and transformed cells
37. Expression of DEP-1, a receptor-like protein tyrosine-phosphatase, is enhanced with increasing cell density
38. Protein tyrosine phosphatase-mediated decrease of epidermal growth factor and platelet-derived growth factor receptor tyrosine phosphorylation in high cell density cultures
39. Tyrosine phosphorylation of inducible nitric oxide synthase: Implications for potential post-translational regulation
40. Oxidant stress in rat liver after lipopolysaccharide administration: Effect of inducible nitric oxide synthase inhibition